Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization.
Ciaglia T, Vestuto V, Di Sarno V, Musella S, Smaldone G, Di Matteo F, Napolitano V, Miranda MR, Pepe G, Basilicata MG, Novi S, Capolupo I, Bifulco G, Campiglia P, Gomez-Monterrey I, Snoeck R, Andrei G, Manfra M, Ostacolo C, Lauro G, Bertamino A.
Ciaglia T, et al. Among authors: lauro g.
Eur J Med Chem. 2024 Feb 15;266:116128. doi: 10.1016/j.ejmech.2024.116128. Epub 2024 Jan 9.
Eur J Med Chem. 2024.
PMID: 38232463
Free article.